[HTML][HTML] Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment

Y Huang, X Guo, Y Wu, X Chen, L Feng, N Xie… - … and Targeted Therapy, 2024 - nature.com
Inflammation-associated diseases encompass a range of infectious diseases and non-
infectious inflammatory diseases, which continuously pose one of the most serious threats to …

Multi-functional chitosan-based nanoparticles for drug delivery: Recent advanced insight into cancer therapy

B Tian, S Hua, J Liu - Carbohydrate Polymers, 2023 - Elsevier
Cancer therapy continues to be a major global concern, with conventional treatments
suffering from low efficacy, untargeted drug delivery, and severe side effects. Recent …

[HTML][HTML] Amelioration of cancer employing chitosan, its derivatives, and chitosan-based nanoparticles: recent updates

T Virmani, G Kumar, A Sharma, K Pathak, MS Akhtar… - Polymers, 2023 - mdpi.com
The limitations associated with the conventional treatment of cancer have necessitated the
design and development of novel drug delivery systems based mainly on nanotechnology …

Current advances in chitosan nanoparticles based oral drug delivery for colorectal cancer treatment

H Choukaife, S Seyam, B Alallam… - International journal …, 2022 - Taylor & Francis
As per the WHO, colorectal cancer (CRC) caused around 935,173 deaths worldwide in 2020
in both sexes and at all ages. The available anticancer therapies including chemotherapy …

Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancer

NA Bhaskaran, SR Jitta, L Kumar, P Sharma… - International Journal of …, 2023 - Elsevier
In the present study, polymeric nanoparticles loaded with IRI and quercetin, a p-gp inhibitor,
were developed to target folate receptors expressed by colon cancer cells for oral targeted …

[HTML][HTML] Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson's disease: interplay between nuclear factor-kappa β …

DM Hassan, AH El-Kamel, EA Allam, BA Bakr… - Drug Delivery and …, 2024 - Springer
Parkinson's disease (PD) is the second most common progressive neurodegenerative
disorder associated with increased oxidative stress, the underlying vital process contributing …

Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer

RP Johnson, CK Ratnacaram, L Kumar, J Jose - Drug Resistance Updates, 2022 - Elsevier
Prostate cancer (PC) is the most prevalent male urogenital cancer worldwide. PC patients
presenting an advanced or metastatic cancer succumb to the disease, even after therapeutic …

Recent advancements in Irinotecan-loaded nanomaterials as a smart drug delivery system for cancer therapy: A state-of-art-review

S Fathi-Karkan, M Qindeel, R Arshad, Z Moafian… - Inorganic Chemistry …, 2024 - Elsevier
The convergence of nanotechnology and medicine has filled a large gap in therapeutic
strategies, improving cancer treatment drastically. In this review paper, current …

[HTML][HTML] Substances of natural origin in medicine: Plants vs. cancer

A Gielecińska, M Kciuk, S Mujwar, I Celik, D Kołat… - Cells, 2023 - mdpi.com
Continuous monitoring of the population's health is the main method of learning about
disease prevalence. National and international data draw attention to the persistently high …

[HTML][HTML] Solid lipid Lyo-Nanosuspension: A promising stabilized oral delivery system for the antihyperglycemic extract of mistletoe Plicosepalus acacia

SZ Alshawwa, GS Labib, SM Badr-Eldin… - Saudi Pharmaceutical …, 2023 - Elsevier
The antihyperglycemic effect of Plicosepalus acaciae (P. acaciae) extract was proven, but it
still needs to be formulated into a suitable dosage form. We aimed at preparing an oral …